Placebo
3152-301-002
Phase 3 small_molecule terminated
Quick answer
Placebo for Nonalcoholic Steatohepatitis is a Phase 3 program (small_molecule) at Tobira Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tobira Therapeutics
- Indication
- Nonalcoholic Steatohepatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated